Fitzgerald, N., Angus, K., Elders, A., de Andrade, M., Raistrick, D., Heather, N., & McCambridge, J. (2016). Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers. Addiction.

Fitzgerald, Niamh, Kathryn Angus, Andrew Elders, Marisa de Andrade, Duncan Raistrick, Nick Heather, and Jim McCambridge. "Weak Evidence On Nalmefene Creates Dilemmas for Clinicians and Poses Questions for Regulators and Researchers." Addiction 2016.

Fitzgerald, Niamh, et al. "Weak Evidence On Nalmefene Creates Dilemmas for Clinicians and Poses Questions for Regulators and Researchers." Addiction 2016.